Organization | University of Medicine and Pharmacy Iuliu Hatieganu

University of Medicine and Pharmacy Iuliu Hatieganu Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial

2011

NCT01459445

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2017

Timeline

NOW

Alternative names

University of Medicine and Pharmacy Iuliu Hatieganu Cluj-Napoca | University Of Medicine and Pharmacy Iuliu Hatieganu, Cluj Napoca | University of Medicine and Pharmacy Iuliu Hatieganu Cluj-Napoca,Romania

Active Ingredients

Drugs in Phase 3 Trials (2)

levobupivacaine (chirocaine) (1 trial)

meperidine (demerol) (1 trial)

Drugs in Other Trials (4)

drospirenone (Yasmin) (1 trial)

ethinyl estradiol (Estinyl) (1 trial)

sitagliptin (januvia) (1 trial)

vitamin d3 (1 trial)

Indications

Overview

Highest Phase: Phase 3
# of Trials: 3
# of Trial APIs: 6